| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ForGrowth III PA B.V. | 7.4% | $47,291,008 | 1,833,333 | ForGrowth III PA B.V. | 23 Oct 2025 | |||
| Redmile Group, LLC | 9.9% | $14,934,463 | 1,765,303 | Redmile Group, LLC | 30 Jun 2025 | |||
| RTW INVESTMENTS, LP | 5.9% | $55,041,487 | 1,637,165 | RTW Investments, LP | 31 Dec 2025 | |||
| VANGUARD GROUP INC | 4.2% | $17,958,239 | 696,188 | The Vanguard Group | 30 Sep 2025 | |||
| Nantahala Capital Management, LLC | 3.8% | -33% | $16,074,692 | -$8,467,788 | 623,282 | -35% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| Deep Track Capital, LP | 0.4% | $3,713,262 | 110,448 | Deep Track Capital, LP | 31 Dec 2025 |
As of 31 Dec 2025, 99 institutional investors reported holding 27,200,695 shares of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT). This represents 98% of the company’s total 27,748,559 outstanding shares.
The largest institutional shareholders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.3% | 2,582,408 | +58% | 2.9% | $87,466,159 |
| FCPM III SERVICES B.V. | 6.6% | 1,833,333 | +433% | 8.1% | $62,094,989 |
| ORBIMED ADVISORS LLC | 5.9% | 1,642,891 | +51% | 1.2% | $55,644,718 |
| RTW INVESTMENTS, LP | 5.9% | 1,637,165 | +11% | 0.56% | $55,450,779 |
| Foresite Capital Management VI LLC | 5.6% | 1,562,500 | 0% | 16% | $52,921,875 |
| Siren, L.L.C. | 5% | 1,375,000 | +137% | 1.4% | $46,571,250 |
| VANGUARD GROUP INC | 4.3% | 1,186,791 | +70% | 0% | $40,196,611 |
| Frazier Life Sciences Management, L.P. | 3.5% | 983,333 | 0.89% | $33,305,489 | |
| BRAIDWELL LP | 3.4% | 929,694 | 1% | $31,488,736 | |
| Redmile Group, LLC | 3.2% | 885,927 | +60% | 2.2% | $30,006,347 |
| PERCEPTIVE ADVISORS LLC | 3% | 825,890 | +349% | 0.51% | $27,972,894 |
| Soleus Capital Management, L.P. | 2.8% | 764,000 | +42% | 1.1% | $25,876,680 |
| Nantahala Capital Management, LLC | 2.7% | 754,153 | +21% | 1.5% | $25,543,162 |
| Ikarian Capital, LLC | 2.4% | 665,271 | +8.2% | 2.9% | $22,532,728 |
| Caligan Partners LP | 2.3% | 644,400 | 2% | $21,825,828 | |
| STATE STREET CORP | 2.3% | 639,804 | +1611% | 0% | $21,670,161 |
| CITADEL ADVISORS LLC | 2.1% | 591,802 | +3711% | 0.01% | $20,044,334 |
| GREAT POINT PARTNERS LLC | 2.1% | 581,187 | 6.4% | $19,684,804 | |
| Octagon Capital Advisors LP | 2.1% | 574,000 | 2.4% | $19,441,380 | |
| ADAR1 Capital Management, LLC | 1.8% | 509,679 | +0.38% | 1.3% | $17,262,828 |
| BlackRock, Inc. | 1.8% | 486,153 | +443% | 0% | $16,466,002 |
| BOONE CAPITAL MANAGEMENT LLC | 1.7% | 470,456 | -40% | 5% | $15,934,345 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.5% | 424,862 | +836% | 0.02% | $14,390,076 |
| MPM BIOIMPACT LLC | 1.4% | 397,906 | 1.5% | $13,477,076 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.4% | 390,747 | +75% | 0.35% | $13,234,601 |